Unitree Robotics: The Humanoid Robot Industry Is Still in the Early Stages of Commercialization

Unitree Robotics announced that the cumulative deviation of its stock's closing price gains over three consecutive trading days has exceeded 30%, constituting an abnormal fluctuation in stock trading. The humanoid robot industry remains in the early stages of commercialization, with uncertainties surrounding technology maturity, the development of downstream market demand, and supply chain support capabilities. If the large-scale commercial deployment of the industry progresses slower than anticipated, the company’s future revenue expansion and earnings realization may be adversely affected, presenting investment risks of valuation correction.